Literature DB >> 9105097

Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients.

K Kurashima1, N Mukaida, M Fujimura, M Yasui, Y Nakazumi, T Matsuda, K Matsushima.   

Abstract

In pulmonary tuberculosis, the proportion of lymphocytes, particularly that of CD4+ T lymphocytes, was increased in bronchoalveolar lavage fluid (BALF), reflecting their protective role against mycobacterial infections. In order to elucidate the mechanisms of lymphocyte accumulation in lungs, we measured the levels of chemokines with potent lymphocyte chemotactic activities, including interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), and, regulated on activation, normal T-cell expressed and secreted (RANTES) present in BALF from patients with pulmonary tuberculosis in acute (n = 10) and convalescent phases (n = 6), as well as normal subjects (n = 10). During the acute phase of the disease, the proportions of lymphocytes and neutrophils were increased, as reported in previous studies. The levels of IL-8, MCP-1, and RANTES in the acute phase of pulmonary tuberculosis were also markedly elevated as compared with those of normal subjects. MCP-1 and RANTES, but not IL-8 levels present in BALF, decreased in the convalescent phase. Moreover, the concentration of RANTES correlated significantly with the absolute number of CD4+ cells in BALF. These data suggest that chemotactic cytokines are differentially produced and participate in the host response to Mycobacterium tuberculosis infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9105097     DOI: 10.1164/ajrccm.155.4.9105097

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  45 in total

1.  Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo.

Authors:  Prachi P Singh; Victoria L Smith; Petros C Karakousis; Jeffery S Schorey
Journal:  J Immunol       Date:  2012-06-20       Impact factor: 5.422

2.  Production of monocyte chemoattractant protein 1 in tuberculosis patients.

Authors:  Y Lin; J Gong; M Zhang; W Xue; P F Barnes
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Tumor necrosis factor-alpha, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis.

Authors:  C A Evans; J Jellis; S P Hughes; D G Remick; J S Friedland
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

4.  Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis.

Authors:  Y Lin; M Zhang; P F Barnes
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

5.  LipC (Rv0220) is an immunogenic cell surface esterase of Mycobacterium tuberculosis.

Authors:  Guomiao Shen; Krishna Singh; Dinesh Chandra; Carole Serveau-Avesque; Damien Maurin; Stéphane Canaan; Rupak Singla; Digambar Behera; Suman Laal
Journal:  Infect Immun       Date:  2011-10-28       Impact factor: 3.441

6.  Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts.

Authors:  Claudia Carranza; Esmeralda Juárez; Martha Torres; Jerrold J Ellner; Eduardo Sada; Stephan K Schwander
Journal:  Am J Respir Crit Care Med       Date:  2005-10-06       Impact factor: 21.405

7.  Mycobacterium bovis bacillus Calmette-Guerin induces CCL5 secretion via the Toll-like receptor 2-NF-kappaB and -Jun N-terminal kinase signaling pathways.

Authors:  Patricia Méndez-Samperio; Artemisa Trejo; Aline Pérez
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

8.  Mycobacterium bovis BCG vaccination augments interleukin-8 mRNA expression and protein production in guinea pig alveolar macrophages infected with Mycobacterium tuberculosis.

Authors:  Mark J Lyons; Teizo Yoshimura; David N McMurray
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  The production of tumour necrosis factor-alpha is decreased in peripheral blood mononuclear cells from multidrug-resistant tuberculosis patients following stimulation with the 30-kDa antigen of Mycobacterium tuberculosis.

Authors:  J-S Lee; C-H Song; J-H Lim; H-J Kim; J-K Park; T-H Paik; C-H Kim; S-J Kong; M-H Shon; S-S Jung; E-K Jo
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

10.  CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis.

Authors:  Zahra Hasan; Jacqueline M Cliff; Hazel M Dockrell; Bushra Jamil; Muhammad Irfan; Mussarat Ashraf; Rabia Hussain
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.